Effects of simvastatin or hormone replacement therapy, or both, on fibrinogen, factor VII, and plasminogen activator inhibitor levels in postmenopausal women with proven coronary artery disease.
Sbarouni
E
E
Onassis Cardiac Surgery Centre, 2nd Department of Cardiology, Athens, Greece.
Melissari
E
E
Kyriakides
Z S
ZS
Kremastinos
D T
DT
D000924:Anticholesteremic Agents / Q000276:immunology / Q000627:therapeutic use; D000941:Antigens / Q000097:blood; D015415:Biomarkers / Q000097:blood; D003327:Coronary Disease / Q000097:blood* / Q000175:diagnosis / Q000188:drug therapy; D018592:Cross-Over Studies; D004359:Drug Therapy, Combination; D004966:Estrogens, Conjugated (USP) / Q000627:therapeutic use; D005167:Factor VII / Q000378:metabolism*; D005260:Female; D005340:Fibrinogen / Q000378:metabolism*; D020249:Hormone Replacement Therapy; D006801:Humans; D006937:Hypercholesterolemia / Q000097:blood / Q000188:drug therapy; D008525:Medroxyprogesterone / Q000627:therapeutic use; D008875:Middle Aged; D015849:Plasminogen Inactivators / Q000097:blood*; D017698:Postmenopause / Q000097:blood*; D045167:Progesterone Congeners / Q000627:therapeutic use; D019821:Simvastatin / Q000627:therapeutic use*
D000924:Anticholesteremic Agents; D000941:Antigens; D015415:Biomarkers; D004966:Estrogens, Conjugated (USP); D015849:Plasminogen Inactivators; D045167:Progesterone Congeners; D005167:Factor VII; D005340:Fibrinogen; D019821:Simvastatin; D008525:Medroxyprogesterone